查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765279

全球解冻系统市场（包括各国市场）

Thawing Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球解冻系统市场（包括各国市场）规模将达到 5.645 亿美元

全球解冻系统市场（包括各国市场）预计在2024年达到2.971亿美元，到2030年将达到5.645亿美元，在2024-2030年的分析期内，复合年增长率为11.3%。血液是本报告分析的细分市场之一，预计其复合年增长率为10.1%，到分析期结束时将达到2.877亿美元。胚胎细分市场在分析期间内的复合年增长率估计为13.2%。

美国市场规模估计为 8,070 万美元，中国市场预计复合年增长率为 10.4%

美国除霜系统各国市场规模预计2024年达到8,070万美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到8,570万美元，在2024-2030年的分析期内，复合年增长率为10.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为9.9%和9.5%。在欧洲，预计德国市场的复合年增长率约为8.0%。

全球解冻系统市场（包括各国市场）－主要趋势与驱动因素摘要

为什么解冻系统（包括各国市场）在生物製药产业受到关注？

各国市场系统在生物製药和医疗保健领域已变得至关重要，因为它们在血浆、血液、疫苗和组织等生物样本的受控解冻中发挥关键作用。这些系统确保精密生物製药在解冻时不会影响其品质和功效。生技药品和细胞治疗方法的兴起大大增加了对先进、精确的自动解冻技术的需求。近年来，采用可程式解冻系统的趋势日益增长，该系统提供即时监控以确保解冻过程的一致性。细胞疗法各国市场的扩张以及对维护生技药品低温运输完整性的日益重视，尤其是在临床试验和研究环境中，也推动了需求的激增。

各个细分市场和最终用途市场如何影响解冻系统市场（包括各国市场）？

解冻系统各国市场依应用和使用规模，可分为手动、自动和桌上型等产品类型。例如，自动解冻系统在生物製药生产和实验室中越来越被采用，用于各国市场解冻样本。最终用户主要包括医院、诊断实验室、生技公司和研究机构。在医院领域，解冻系统对于输血所需的血液和血浆的製备至关重要；而在研究机构，这些系统对于处理冷冻细胞和各国市场至关重要。此外，各国市场诊所和脐带血库对解冻系统的使用日益增加也促进了市场扩张。

解冻系统市场（包括各国市场）发生了哪些新趋势？

解冻系统市场的最新技术创新专注于提高效率、精度和自动化程度。例如，开发能够容纳各种样本量并提供可程式设计功能以客製化解冻通讯协定的系统日益成为一种趋势。随着先进感测器和数据管理解决方案的日益各国市场，这些系统正在转变为确保符合监管标准的关键工具，尤其是在生技药品的储存和处理方面。另一个值得注意的趋势是越来越多地使用一次性解冻袋，以最大限度地降低污染风险并提高操作便利性。此外，随着对个人化医疗和各国市场细胞疗法的需求不断增长，解冻系统也在不断发展，以满足这些不断增长的行业的复杂需求。

哪些因素推动了除霜系统各国市场的成长？

解冻系统市场的成长受到多种因素的推动，包括对生物製药的需求不断增长、需要高级治疗的慢性病患病率不断上升以及生技药品製造业的不断扩张。随着各国市场公司在细胞和基因治疗研发方面投入巨资，迫切需要精确的解冻解决方案。此外，监管机构正在为处理生物材料设定更高的标准，这刺激了对合规解冻技术的需求。对维护低温运输完整性的日益重视，尤其是在疫苗大规模分发的情况下，也促进了市场的成长。最后，自动化和节能解冻系统的开发，可以降低营运成本并提高生产力，进一步推动了各国市场扩张。

部分

样本类型（血液、胚胎、卵子、精液）、最终用户（血库、医院、组织库、製药和生物技术公司、其他最终用户）

受访公司范例

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP15187

Global Thawing Systems Market to Reach US$564.5 Million by 2030

The global market for Thawing Systems estimated at US$297.1 Million in the year 2024, is expected to reach US$564.5 Million by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Blood, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$287.7 Million by the end of the analysis period. Growth in the Embryo segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.7 Million While China is Forecast to Grow at 10.4% CAGR

The Thawing Systems market in the U.S. is estimated at US$80.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Thawing Systems Market - Key Trends and Drivers Summarized

Why Are Thawing Systems Gaining Traction in the Biopharmaceutical Industry?

Thawing systems have become essential in the biopharmaceutical and healthcare sectors due to their pivotal role in the controlled thawing of biological samples such as plasma, blood, vaccines, and tissues. These systems ensure that sensitive biological products are thawed without compromising their quality and efficacy. With the rise of biologics and cell-based therapies, the need for advanced, precise, and automated thawing technologies has grown significantly. In recent years, there has been an increasing trend toward the adoption of programmable thawing systems that offer real-time monitoring, ensuring consistent thawing processes. This surge in demand is also driven by the expanding cell therapy market and the growing emphasis on maintaining cold chain integrity for biologics, especially in clinical trials and research settings.

How Are Different Segments and End-Use Markets Shaping Thawing Systems?

The market for thawing systems is categorized by product types such as manual, automated, and benchtop systems, which cater to different applications and scales of use. Automated thawing systems, for instance, have seen increased adoption in biopharmaceutical manufacturing and research laboratories, where they are used for the large-scale thawing of samples. The end-user segments are primarily composed of hospitals, diagnostic laboratories, biotechnology firms, and research institutions. In the hospital segment, thawing systems are crucial for preparing blood and plasma for transfusions, while in research labs, these systems are essential for processing frozen cells and tissues. Additionally, the growing use of thawing systems in fertility clinics and cord blood banks is also contributing to the market’s expansion.

What Emerging Trends Are Transforming the Thawing Systems Market?

Recent innovations in the thawing systems market have focused on improving efficiency, precision, and automation. For instance, there is a rising trend toward developing systems that can handle a broad range of sample volumes while offering programmable features for customized thawing protocols. The growing integration of advanced sensors and data management solutions has transformed these systems into critical tools for ensuring compliance with regulatory standards, particularly in the storage and handling of biologics. Another notable trend is the increased use of single-use thawing bags that minimize contamination risks and offer greater operational convenience. Furthermore, as demand for personalized medicine and advanced cell therapies continues to rise, thawing systems are evolving to meet the complex needs of these growing fields.

What Factors Are Driving the Growth of the Thawing Systems Market?

The growth in the thawing systems market is driven by several factors, including the rising demand for biopharmaceuticals, the increasing prevalence of chronic diseases requiring advanced therapies, and the expansion of the biologics manufacturing sector. With biopharmaceutical companies investing heavily in research and development for cell and gene therapies, there is a pressing need for precise thawing solutions. Moreover, regulatory agencies are setting higher standards for the handling of biological materials, which is fueling the demand for compliant thawing technologies. The growing emphasis on maintaining cold chain integrity, particularly in the wake of large-scale vaccine distribution efforts, is also contributing to market growth. Finally, the development of automated and energy-efficient thawing systems, which reduce operational costs and enhance productivity, is further driving the market’s expansion.

SCOPE OF STUDY:

The report analyzes the Thawing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sample Type (Blood, Embryo, Ovum, Semen); End-Use (Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Thawing Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Automated Thawing Technologies Propel Growth of Thawing Systems Market
    • Rising Adoption of Biopharmaceuticals Spurs Demand for Efficient Thawing Solutions
    • Increased Focus on Cold Chain Logistics Expands Addressable Market Opportunity
    • Growing Investment in Cell and Gene Therapy Strengthens Business Case for Thawing Systems
    • Emergence of Rapid Thawing Techniques Accelerates Demand for Innovative Thawing Systems
    • Rising Focus on Sample Integrity in Clinical Labs Spurs Need for Advanced Thawing Solutions
    • Increased Utilization of Frozen Stem Cells and Tissues Propels Market for Thawing Systems
    • Technological Innovations in Cryopreservation Fuel Market Growth for Efficient Thawing
    • Growing Number of Biobanks and Biorepositories Expands Demand for Automated Thawing Systems
    • Increasing Emphasis on Sustainability Spurs Development of Energy-efficient Thawing Systems
    • Growing Adoption of Single-use Technologies in Bioprocessing Accelerates Thawing Systems Market
    • Expansion of Biopharmaceutical Manufacturing Capabilities Boosts Demand for Thawing Equipment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thawing Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Embryo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Embryo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ovum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ovum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Semen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Semen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tissue Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Tissue Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Germany 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Italy 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of World 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION